Sciatica that persists or returns after spine surgery may indicate a residual or adjacent annular tear. In many cases, intra-annular fibrin injection can address the underlying tear without revision surgery. Candidates are evaluated individually and outcomes vary; a clinical evaluation helps determine whether regenerative care is an appropriate next step.

Key Takeaways

• Persistent post-surgical sciatica is often classified as failed back surgery syndrome (FBSS).
• Annular tears frequently remain or develop adjacent to the original surgical site after disc surgery.
• Intra-annular fibrin injection may address the underlying tear source without additional surgery in eligible candidates.
• Revision surgery carries added complexity and lower success rates in many patients with FBSS.
• A thorough clinical evaluation guides the most appropriate path forward for each patient.

Understanding Post-Surgical Sciatica

When sciatica persists after a discectomy, laminectomy, or fusion, the condition is often categorized as failed back surgery syndrome (FBSS). FBSS does not mean surgery was performed incorrectly — it means the pain source has not been fully resolved. In many patients, an annular tear at the original level or at an adjacent disc continues to irritate the sciatic nerve, producing symptoms similar to those that prompted surgery in the first place.

Common contributors to post-surgical sciatica include residual annular tears, recurrent disc herniation, epidural fibrosis (scar tissue formation), and adjacent segment degeneration. Identifying which factor is driving symptoms requires updated imaging and a clinical evaluation. Learn more about options after failed back surgery.

Treatment Options

Patients with post-surgical sciatica are evaluated individually, and the appropriate path depends on imaging findings, symptom history, and overall clinical picture. Options our clinical team discusses include:

• Continued or adjusted conservative care — physical therapy, activity modification, and anti-inflammatory management help reduce symptoms in some patients.
• Image-guided injections — epidural steroid injections provide temporary relief when inflammation is a primary driver; candidacy varies.
• Spinal cord stimulation — an option for carefully selected FBSS patients when other approaches have not produced adequate relief.
• Intra-annular fibrin injection (biologic disc repair) — an FDA-approved fibrin sealant is delivered directly into the annular tear under image guidance, supporting the disc’s natural healing response and potentially reducing nerve irritation without the added risks of revision surgery.
• Revision surgery — appropriate in select cases such as confirmed hardware failure, significant instability, or new structural pathology on updated imaging.

How Biologic Disc Repair Addresses the Tear Source

In many patients with post-surgical sciatica, the annular tear that surgery did not seal — or one that developed at an adjacent level after fusion altered spinal mechanics — remains the active pain driver. Intra-annular fibrin injection targets that tear directly. The fibrin sealant creates a scaffold that supports tissue repair and reduces the inflammatory response irritating the sciatic nerve in eligible candidates.

Recovery after the fibrin procedure is typically less demanding than revision surgery, and the approach does not foreclose future surgical options if additional intervention becomes necessary. Outcomes vary by patient, and candidacy is determined through a comprehensive evaluation of imaging, symptom history, and prior treatment.

Frequently Asked Questions

How soon after spine surgery can I be evaluated for intra-annular fibrin injection?

Timing depends on the type of surgery performed and the extent of postoperative healing. Our clinical team reviews imaging and history once the standard healing window has passed, though the specific timeline varies by case. Patients experiencing persistent symptoms are encouraged to reach out for an initial evaluation as soon as concerns arise.

Can multiple discs be treated with intra-annular fibrin injection?

In many cases, yes. When imaging identifies annular tears at more than one level, both discs are assessed for treatment in a single procedure. Candidacy for multi-level treatment is determined during the clinical evaluation process.

Will I still be a candidate for revision surgery after biologic disc repair?

Biologic disc repair is designed to complement rather than foreclose future options. Patients who undergo the fibrin procedure and later require surgical intervention are evaluated individually — the procedure does not typically limit future surgical candidacy.

Does VA coverage or Mission Act apply to post-surgical sciatica treatment?

Many veterans with service-connected back conditions qualify for VA benefits or Mission Act community care to access non-surgical spine treatment. Eligibility depends on the individual’s service-connected rating and VA determination. Our team helps patients work through the benefits and coverage process.

Sources & Further Reading

• National Institutes of Health (NIH) — Failed Back Surgery Syndrome literature
• American Academy of Family Physicians (AAFP) — Postoperative spine care guidelines
• U.S. Department of Veterans Affairs — Mission Act community care
• Centers for Disease Control and Prevention (CDC) — Chronic pain management

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Consult a qualified physician regarding your specific condition or any treatment decision.

If sciatica has persisted after spine surgery, our clinical team evaluates each patient individually to identify the underlying source and determine whether biologic disc repair or another approach is appropriate. See whether you may be a candidate for non-surgical disc treatment.